End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-11 pm EDT
|
5-day change
|
1st Jan Change
|
22.99
CNY
|
-0.22%
|
|
+3.00%
|
-5.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,717
|
17,643
|
22,893
|
19,924
|
22,872
|
21,571
|
-
|
-
|
Enterprise Value (EV)
1 |
9,717
|
16,627
|
22,893
|
19,207
|
22,668
|
21,365
|
21,164
|
21,571
|
P/E ratio
|
248
x
|
-111
x
|
106
x
|
51.9
x
|
101
x
|
50.1
x
|
36.2
x
|
26.9
x
|
Yield
|
0.2%
|
0.16%
|
0.08%
|
0.23%
|
-
|
0.43%
|
0.66%
|
1%
|
Capitalization / Revenue
|
8.46
x
|
9.71
x
|
9.72
x
|
7.32
x
|
8.58
x
|
6.61
x
|
5.6
x
|
4.78
x
|
EV / Revenue
|
8.46
x
|
9.15
x
|
9.72
x
|
7.06
x
|
8.5
x
|
6.55
x
|
5.49
x
|
4.78
x
|
EV / EBITDA
|
-
|
-153
x
|
56.9
x
|
29.6
x
|
45.6
x
|
27
x
|
21.2
x
|
16.3
x
|
EV / FCF
|
-
|
91.5
x
|
-
|
-175
x
|
-51.3
x
|
737
x
|
86
x
|
-
|
FCF Yield
|
-
|
1.09%
|
-
|
-0.57%
|
-1.95%
|
0.14%
|
1.16%
|
-
|
Price to Book
|
2.57
x
|
4.97
x
|
5.68
x
|
4.79
x
|
5.12
x
|
4.49
x
|
4.05
x
|
3.56
x
|
Nbr of stocks (in thousands)
|
981,468
|
933,022
|
940,539
|
935,824
|
945,118
|
938,283
|
-
|
-
|
Reference price
2 |
9.900
|
18.91
|
24.34
|
21.29
|
24.20
|
22.99
|
22.99
|
22.99
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,149
|
1,817
|
2,356
|
2,721
|
2,667
|
3,262
|
3,853
|
4,512
|
EBITDA
1 |
-
|
-108.6
|
402.5
|
649.8
|
496.8
|
792.3
|
998.9
|
1,321
|
EBIT
1 |
19.35
|
-215.9
|
289.5
|
488.6
|
319
|
582.9
|
791.8
|
1,079
|
Operating Margin
|
1.68%
|
-11.88%
|
12.29%
|
17.95%
|
11.96%
|
17.87%
|
20.55%
|
23.91%
|
Earnings before Tax (EBT)
1 |
30.77
|
-91.87
|
293.4
|
481.8
|
318.5
|
591.2
|
799.2
|
1,078
|
Net income
1 |
34.09
|
-159.8
|
213.5
|
390
|
222
|
432.2
|
598.1
|
807.2
|
Net margin
|
2.97%
|
-8.8%
|
9.06%
|
14.33%
|
8.32%
|
13.25%
|
15.52%
|
17.89%
|
EPS
2 |
0.0400
|
-0.1700
|
0.2300
|
0.4100
|
0.2400
|
0.4588
|
0.6359
|
0.8543
|
Free Cash Flow
1 |
-
|
181.7
|
-
|
-109.7
|
-442.2
|
29
|
246
|
-
|
FCF margin
|
-
|
10%
|
-
|
-4.03%
|
-16.58%
|
0.89%
|
6.38%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
3.66%
|
24.63%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
6.71%
|
41.13%
|
-
|
Dividend per Share
2 |
0.0200
|
0.0300
|
0.0200
|
0.0500
|
-
|
0.1000
|
0.1525
|
0.2300
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q2
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
61.14
|
Net margin
|
-
|
EPS
2 |
0.0634
|
Dividend per Share
|
-
|
Announcement Date
|
8/18/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,016
|
-
|
716
|
204
|
206
|
407
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
182
|
-
|
-110
|
-442
|
29
|
246
|
-
|
ROE (net income / shareholders' equity)
|
0.91%
|
-4.39%
|
5.64%
|
8.97%
|
4.94%
|
9.11%
|
11.4%
|
13.2%
|
ROA (Net income/ Total Assets)
|
0.84%
|
-3.7%
|
4.47%
|
7.27%
|
3.6%
|
6.12%
|
7.32%
|
8.62%
|
Assets
1 |
4,083
|
4,325
|
4,779
|
5,364
|
6,165
|
7,062
|
8,177
|
9,368
|
Book Value Per Share
2 |
3.860
|
3.800
|
4.280
|
4.450
|
4.730
|
5.120
|
5.680
|
6.460
|
Cash Flow per Share
2 |
0.2000
|
0.4200
|
0
|
0.5900
|
0.5700
|
0.6700
|
1.010
|
1.050
|
Capex
1 |
206
|
207
|
372
|
673
|
977
|
429
|
438
|
509
|
Capex / Sales
|
17.93%
|
11.38%
|
15.77%
|
24.71%
|
36.61%
|
13.14%
|
11.35%
|
11.28%
|
Announcement Date
|
2/20/20
|
4/9/21
|
4/14/22
|
4/10/23
|
4/9/24
|
-
|
-
|
-
|
Last Close Price
22.99
CNY Average target price
25.67
CNY Spread / Average Target +11.64% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.00% | 2.98B | | +24.08% | 70.28B | | -3.00% | 47.63B | | +25.57% | 45.14B | | +34.90% | 29.06B | | +7.71% | 19.18B | | +15.37% | 17.52B | | -8.45% | 15.54B | | -23.96% | 15.38B | | -28.89% | 12.23B |
Other Specialty Chemicals
|